References
- SHannon, M.; Neuman, M. Yohimbine. Pediatr. Emerg. Care. 2000, 16(16), 49–50.
- Anderson, C.; Anderson, D.; Harre, N.; Wade, N. Case Study: Two Fatal Case Reports of Acute Yohimbine Intoxication. J. Anal. Toxicol. 2013, 37(8), 611–614.
- Swann, A. C.; Lijffijt, M.; Lane, S. D.; Cox, B.; Steinberg, J. L.; Moeller, F. G. Norepinephrine and Impulsivity: Effects of Acute Yohimbine[J]. Psychopharmacology 2013, 229(1), 83–94.
- Bonaerense, A. F. Tyler ve, brady lr, robbers je. Pharmacognosy, 9th ed. Philadelphia, USA: Lea & Febiger, 1988, p. 519 (Acta Farm. Bonaerense).
- Tam, S. W.; Worcel, M.; Wyllie, M. Yohimbine: A Clinical Review. Pharmacol. Ther. 2011, 91(3), 215–243.
- Cohen, P. A.; Wang, Y. H.; Maller, G.; DeSouza, R.; Khan, I. A. Pharmaceutical Quantities of Yohimbine Found in Dietary Supplements in the USA. Drug Test. Anal. 2016, 8(3–4), 357–369.
- Ajayi, A. A.; Newaz, M.; Hercule, H.; Saleh, M.; Bode, C. O.; Oyekan, A. O. Endothelin-like Action of Pausinystalia yohimbe Aqueous Extract on Vascular and Renal Regional Hemodynamics in Sprague Dawley Rats. Methods Find. Exp. Clin. Pharmacol. 2003, 25(10), 817–822.
- Meyerbroeker, K.; Powers, M. B.; Van Stegeren, A.; Emmelkamp, P. M. G. Does Yohimbine Hydrochloride Facilitate Fear Extinction in Virtual Reality Treatment of Fear of Flying? A Randomized Placebo-controlled Trial. Psychother. Psychosom. 2012, 81 (1), 29–37.
- Conrad, K. L.; Davis, A. R.; Silberman, Y.; Sheffler, D. J.; Shields, A. D.; Saleh, S. A.; Sen, N.; Matthies, H. J. G.; Javitch, J. A.; Lindsley, C. W.; Winder, D. G. Yohimbine Depresses Excitatory Transmission in BNST and Impairs Extinction of Cocaine Place Preference Through Orexin-dependent, Norepinephrine-independent Processes. Neuropsychopharmacology 2012, 37(10), 2253–2266.
- Cimolai, N.; Cimolai, T. Yohimbine Use for Physical Enhancement and its Potential Toxicity. J. Diet. Suppl. 2011, 8(4), 346–354.
- Pietsch, J.; Gunther, J.; Henle, T.; Dressler, J. Simultaneous Determination of Thirteen Plant Alkaloids in a Human Specimen by SPE and HPLC. J. Sep. Sci. 2008, 31(13), 2410–2416.
- DiMaio Knych, H. K.; Covarrubias, V.; Steffey, E. P. Effect of Yohimbine on Detomidine Induced Changes in Behavior, Cardiac and Blood Parameters in the Horse. Vet. Anaesth. Analg. 2012, 239(6), 574–583.
- Lee, S.; Kang, S. Y.; Ji, D.; Baeck, S.; Lee, S.; Oh, S. M.; Chung, K. H. Quantitative LC–MS/MS Method in Urine for the Detection of Drugs Used to Reverse the Effects of Chemical Castration. Anal. Bioanal. Chem. 2013, 405(10), 3185–3194.
- Meyer, M. R.; Caspar, A.; Brandt, S. D.; Maurer, H. H. A Qualitative/Quantitative Approach for the Detection of 37 Tryptamine-Derived designer drugs, 5 β-carbolines, Ibogaine, and Yohimbine in Human Urine and Plasma Using Standard Urine Screening and Multi-analyte Approaches. Anal. Bioanal. Chem. 2013, 406(1), 225–237.
- Vuckovic, D.; Zhang, X.; Cudjoe, E.; Pawliszyn, J. Solid-phase Microextraction in Bioanalysis: New Devices and Directions. J. Chromatogr. A 2010, 1217(25), 4041–4060.
- Ahmadi, F.; Karamian, E. Computational Aided-molecular Imprinted Polymer Design for Solid Phase Extraction of Metaproterenol from Plasma and Determination by Voltammetry Using Modified Carbon Nanotube Electrode. Iran. J. Pharm. Res. 2014, 13 (2), 417–429.
- Moein, M. M.; Said, R.; Bassyouni, F.; Abdel-Rehim, M. Solid Phase Microextraction and Related Techniques for Drugs in Biological Samples. J. Anal. Methods Chem. 2014, 2014, 1–24.
- Pawliszyn, J.; Pawliszyn, B.; Pawliszyn, M. Solid Phase Microextraction (SPME). The Chemical Educator, 1997, 2(4), 1–7.
- Chen, J.; Min, X.; Li, P.; Chen, W.; Tian, D.; Chen, Q. Sensitive Determination of Four Camptothecins by Solid-phase Microextraction-HPLC Based on a Boronic Acid Contained Polymer Monolithic Layer. Anal. Chim. Acta 2015, 879, 41–47.
- Zhang, W.; Chen, Z. Preparation of Micropipette Tip-based Molecularly Imprinted Monolith for Selective Micro-solid Phase Extraction of Berberine in Plasma and Urine Samples. Talanta 2013, 103, 103–109.